Purchase Order 75N95D23P00090
- Not listed
- The National Institute on Aging awarded a $24,995 firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for software licenses and device warranty services related to the PromethION-24 sequencer. The contract was awarded on August 15, 2025, with an ultimate completion date of August 14, 2026, and will be performed in New York, NY. This award carries no set-aside designation and represents Oxford Nanopore's continued provision of next-generation sequencing technologies to federal...
- The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $197,755 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of a PROMETHION 24 THIRD GENERATION SEQUENCER to support the NIA's Computational Biology & Genomics Core, which provides next-generation sequencing services for aging-related research at the NIA Intramural...
- This firm fixed-price purchase order is valued at $30,000 and was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Oxford Nanopore Technologies Inc. The order is for a software license and device warranty to support the Nanopore Promethion Long Read Sequencer serial number P48_051 located at the NIH in Bethesda, Maryland. The sequencing platform will be used over the period of performance from July 2023 to July 2024 by the NIH's...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $185,835 firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for the delivery of PromethION flow cell packs for long-read DNA and RNA/cDNA sequencing. Per the solicitation, the Government sought these products and associated packaging, marking, shipping, and delivery services to 251 Bayview Blvd in Baltimore, Maryland within 90 days of order receipt. As specified,...
- This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a license and warranty for a PromethION 48 DNA/RNA sequencing system, with a period of performance through October 27, 2029. Oxford Nanopore Technologies has secured multiple prime contracts and...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a software license and device warranty for a Nanopore PromethION long-read sequencer, with a ceiling value of $120,000.00. The contract period of performance is from May 28, 2023, to May 27, 2027. The original solicitation was a pre-solicitation Sources Sought notice,...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $35,000 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a software license and device warranty to support the Oxford Nanopore Promethion 24A sequencing platform. The contract has a period of performance from January 19, 2024 through January 19, 2025. Oxford Nanopore Technologies Inc. will deliver the requested products and services as the prime...
- This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
- This federal contract award is for the provision of Oxford Nanopore long read sequencing kits to the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The $550,333 firm-fixed-price purchase order was awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company specializing in nanopore-based sequencing technologies. The contract does not have a set-aside designation. The contract was awarded to administratively...
- This is a $23,050.00 firm fixed price purchase order awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of a PromethION 2 Solo CAPEX Sequencing Unit, a next-generation genomic sequencing platform developed by Oxford Nanopore. This award is not associated with a set-aside program and is the latest in a...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $20,000 purchase order to Oxford Nanopore Technologies Inc. for SOFTWARE LICENSE AND DEVICE WARRANTY SERVICES - PROMETHION-24 SEQUENCER. Oxford Nanopore Technologies Inc. will provide software licenses and device warranty services for its PromethION-24 sequencer under the firm fixed price contract. Performance will take place in Baltimore, Maryland over a one year period from August 2023 through August 2024. No subcontractors or set aside designations were identified. The National Institute on Aging supports biomedical research on the aging process in order to better understand the nature of aging and age-related diseases, in keeping with the contract's purpose.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 8/14/23 |